Fenny – Page 302 – Press Release Worldwide

×

Medication Adherence Market is expected to grow from 7.2 USD Billion in 2025 to 14 USD Billion by 2035

Medication Adherence Market is expected to grow from 7.2 USD Billion in 2025 to 14 USD Billion by 2035

Parkinson's Disease Treatment Market is expected to grow from 6.3 USD Billion in 2025 to 10.2 USD Billion by 2035

Parkinson’s Disease Treatment Market is expected to grow from 6.3 USD Billion in 2025 to 10.2 USD Billion by 2035

Portable Ultrasound Bladder Scanner Market is expected to grow from 1,023 USD Million in 2025 to 2,500 USD Million by 2035

Portable Ultrasound Bladder Scanner Market is expected to grow from 1,023 USD Million in 2025 to 2,500 USD Million by 2035

PVDF Membrane Market is expected to grow from 1,697.6 USD Million in 2025 to 3,500 USD Million by 2035

PVDF Membrane Market is expected to grow from 1,697.6 USD Million in 2025 to 3,500 USD Million by 2035

Epilepsy Market Size to Surpass USD 590.2 Million by 2030 at 7.20% CAGR – Report by Market Research Future (MRFR)

Epilepsy Market Size to Surpass USD 590.2 Million by 2030 at 7.20% CAGR – Report by Market Research Future (MRFR)

Botulinum Toxin Market Size Worth USD 6.5 Billion by 2030 at 11.80% CAGR – Report by Market Research Future (MRFR)

Botulinum Toxin Market Size Worth USD 6.5 Billion by 2030 at 11.80% CAGR – Report by Market Research Future (MRFR)

The Global Cereals Market is expected to reach USD 49.37 billion by 2030.

The Global Cereals Market is expected to reach USD 49.37 billion by 2030.

Concussions Market Size to Surpass USD 1337.17 Million by 2030 at 3.33% CAGR – Report by Market Research Future (MRFR)

Concussions Market Size to Surpass USD 1337.17 Million by 2030 at 3.33% CAGR – Report by Market Research Future (MRFR)

Neuropathic Pain Market Size Worth USD 4.9 Billion by 2030 at 4.72% CAGR – Report by Market Research Future (MRFR)New York, USA, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Neuropathic Pain Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Neuropathic Pain Market Information by Type, Indication, Diagnosis, Treatment, Distribution Channel, End user and Region- Forecast till 2030” the market size was prized at USD 2.4 billion in 2021. The neuropathic pain industry is projected to grow from USD 2.6 Billion in 2022 to USD 4.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.72% during the forecast period (2022 - 2030) Market Scope: An increase in the geriatric population is predicted to increase the demand for neuropathic pain management services. The rise in diabetes and cancer prevalence, the approval of novel neuropathic pain treatment options, the proliferation of pain management clinics, and the rise in demand for neuropathic pain treatment are the key market drivers enhancing the market growth. Infection, trauma, or failure in the nerve system are the most common causes of neuropathic pain, a condition characterized by chronic pain. Well-known neuropathic pain syndromes include postherpetic neuralgia, central pain syndromes, traumatic mononeuropathy, postherpetic neuralgia, complex regional pain syndrome, and post-surgical pain syndromes. Injury to the tissues is often the trigger for neuropathic pain, a complex and chronic pain state. Injuries to the nervous system can cause pain signal miscommunication between different brain regions. When a nerve fiber is damaged, it affects more than just the area directly around the injury. Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/1390

Neuropathic Pain Market Size Worth USD 4.9 Billion by 2030 at 4.72% CAGR – Report by Market Research Future (MRFR)New York, USA, Feb. 07, 2023 (GLOBE NEWSWIRE) — Neuropathic Pain Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Neuropathic Pain Market Information by Type, Indication, Diagnosis, Treatment, Distribution Channel, End user and Region- Forecast till 2030” the market size was prized at USD 2.4 billion in 2021. The neuropathic pain industry is projected to grow from USD 2.6 Billion in 2022 to USD 4.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.72% during the forecast period (2022 – 2030) Market Scope: An increase in the geriatric population is predicted to increase the demand for neuropathic pain management services. The rise in diabetes and cancer prevalence, the approval of novel neuropathic pain treatment options, the proliferation of pain management clinics, and the rise in demand for neuropathic pain treatment are the key market drivers enhancing the market growth. Infection, trauma, or failure in the nerve system are the most common causes of neuropathic pain, a condition characterized by chronic pain. Well-known neuropathic pain syndromes include postherpetic neuralgia, central pain syndromes, traumatic mononeuropathy, postherpetic neuralgia, complex regional pain syndrome, and post-surgical pain syndromes. Injury to the tissues is often the trigger for neuropathic pain, a complex and chronic pain state. Injuries to the nervous system can cause pain signal miscommunication between different brain regions. When a nerve fiber is damaged, it affects more than just the area directly around the injury. Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/1390